ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2026
Impact of particulate matter 2.5 exposure on severity of pediatric chronic rhinitis: A prospective cohort study.
Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of particulate matter 2.5 exposure on severity of pediatric chronic rhinitis: A prospective cohort study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundParticulate matter with a diameter of ≤2.5 micrometers (PM
objectivesTo determine the association between PM
methodsThis prospective longitudinal study (July 2024-August 2025) followed children with chronic rhinitis in the Bangkok Metropolitan Region. Rhinitis symptom severity was assessed weekly using a visual analog scale (VAS), with covariates such as medication use and concurrent respiratory infections. A 1-week average PM
resultsAmong 146 children followed for a median of 52 weeks, higher PM
conclusionHigher short-term ambient PM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.